Mark Rosenblatt

Technology | Investing | Foreign Policy

📍 New York City Metropolitan Area, United States🔄 Updated September 2026💼 6 investments📅 14 years investing🗓 Last invested May 2019
VC🌍 United States
6
Total investments
3
Early stage
3
Mid stage
0
Late stage
14y
Years active

Portfolio

6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
May 2019
BactoByte aims to empower caregivers with one-hour bacterial diagnostics and antibiotic screening capability to improve outcomes, reduce mis-diagnostics, and lower health care costs. Based on our proprietary basic method, BactoByte’s assay delivers precise and cost-effective identification and direct antibiotics susceptibility testing with 80-90% improvement of standard turnaround time. Time reduction, sensitivity, and specificity results in decreased mortality rates, fewer hospital days, and avoidance of associated costs of $1K-50K per patient. BactoByte has technology validation and partnerships with leading medical centers.
Board Observer
May 2017
Aromyx has introduced unbiased, quantitative measurement of how humans perceive taste and smell. We have merged biotechnology, data science, and AI to replicate the power of flavors and aromas. Our technology allows companies to optimize flavors and scents that drive product development, consumer preferences, and purchase behavior.
Board Member
Feb 2015
See how much you could save 🤑 https://insurify.com/ Insurify is the smart, virtual insurance platform for your auto, home, and life insurance needs. Were powered by a robust technology suite that provides fast, accurate, and personalized recommendations and quotes to help you make confident decisions about your insurance coverage and carrier. Save up to $400/year. Featured on @WSJ @TechCrunch @Forbes @lifehacker @CNET
Board Member
Aug 2014
StatSocial delivers the industry’s leading social audience insights platform, Silhouette™, empowering marketers to identify and reach the audiences that matter most to their brand. Using Silhouettes patented Identity Graph, marketers can merge an individual’s interactions across major social and community platforms into a single verified identity. With over 200K attributes at their fingertips, marketers can build audiences based on an individuals brand affinities, interests, passions, preferred media channels, trusted influencers and more. Silhouette’s ability to integrate with third-party systems makes it possible for marketers to deliver and activate on social audience insight data to fuel market research and panel initiatives, influencer and social measurement, paid media activation, data enrichment and more.
Board Observer
Jan 2013
Luminoso Technologies’ mission is to deliver human-like understanding of language to drive better business outcomes. Born out of the MIT Media Lab, Luminoso’s natural language understanding platform solves the problem of computers not understanding humans’ words, thoughts, or emotions. Using innovative AI & Machine Learning methods to achieve best-in-class natural language understanding, Luminoso enables businesses to identify key issues and trends from their underutilized text data, thereby providing the insights necessary to adapt more quickly and effectively. Watch a 60 second overview of Luminoso https://www.youtube.com/watch?v=AIQCuQ77qKU
Board Member
Mar 2012
RiverMeadow is a Multi-Cloud Migration Services and DR Company with Product capability that will Lift, Optimize and Protect workloads faster, better and more cost-effectively. To find out more about how you can join RiverMeadow’s fast-growing network of global partners and do more with cloud confidence visit www.rivermeadow.com.
Experience · 8 entries
All (8)
Investments (6)
Founder (1)
Board (6)
2019
Board Member
May 2019
BactoByte aims to empower caregivers with one-hour bacterial diagnostics and antibiotic screening capability to improve outcomes, reduce mis-diagnostics, and lower health care costs. Based on our proprietary basic method, BactoByte’s assay delivers precise and cost-effective identification and direct antibiotics susceptibility testing with 80-90% improvement of standard turnaround time. Time reduction, sensitivity, and specificity results in decreased mortality rates, fewer hospital days, and avoidance of associated costs of $1K-50K per patient. BactoByte has technology validation and partnerships with leading medical centers.
2017
Board Observer
May 2017
Aromyx has introduced unbiased, quantitative measurement of how humans perceive taste and smell. We have merged biotechnology, data science, and AI to replicate the power of flavors and aromas. Our technology allows companies to optimize flavors and scents that drive product development, consumer preferences, and purchase behavior.
2015
Board Member
Feb 2015
See how much you could save 🤑 https://insurify.com/ Insurify is the smart, virtual insurance platform for your auto, home, and life insurance needs. Were powered by a robust technology suite that provides fast, accurate, and personalized recommendations and quotes to help you make confident decisions about your insurance coverage and carrier. Save up to $400/year. Featured on @WSJ @TechCrunch @Forbes @lifehacker @CNET
2014
Board Member
Aug 2014
StatSocial delivers the industry’s leading social audience insights platform, Silhouette™, empowering marketers to identify and reach the audiences that matter most to their brand. Using Silhouettes patented Identity Graph, marketers can merge an individual’s interactions across major social and community platforms into a single verified identity. With over 200K attributes at their fingertips, marketers can build audiences based on an individuals brand affinities, interests, passions, preferred media channels, trusted influencers and more. Silhouette’s ability to integrate with third-party systems makes it possible for marketers to deliver and activate on social audience insight data to fuel market research and panel initiatives, influencer and social measurement, paid media activation, data enrichment and more.
2013
Board Observer
Jan 2013
Luminoso Technologies’ mission is to deliver human-like understanding of language to drive better business outcomes. Born out of the MIT Media Lab, Luminoso’s natural language understanding platform solves the problem of computers not understanding humans’ words, thoughts, or emotions. Using innovative AI & Machine Learning methods to achieve best-in-class natural language understanding, Luminoso enables businesses to identify key issues and trends from their underutilized text data, thereby providing the insights necessary to adapt more quickly and effectively. Watch a 60 second overview of Luminoso https://www.youtube.com/watch?v=AIQCuQ77qKU
Show all 8 entries ↓
Investment activity
2012–2019 · 6 investments
201212013120141201512017120191
Recent (last 2 years)Earlier